Nonoperating Income (Expense) in USD of Applied Therapeutics, Inc. from Q1 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Applied Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and change rate from Q1 2018 to Q3 2025.
  • Applied Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending 30 Sep 2025 was -$2.23M, a 94.3% increase year-over-year.
  • Applied Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending 30 Sep 2025 was $80.3M.
  • Applied Therapeutics, Inc. annual Nonoperating Income (Expense) for 2024 was -$1.33M, a 97.6% increase from 2023.
  • Applied Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was -$55.2M, a 12595% decline from 2022.
  • Applied Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $442K, a 1200% increase from 2021.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Change (%)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Change (%)

Applied Therapeutics, Inc. Quarterly Nonoperating Income (Expense) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $80.3M -$2.23M +$36.6M +94.3% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $43.7M $1.77M -$21.6M -92.4% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 $65.2M $3.7M +$66.5M 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 -$1.33M $77M +$93.7M 01 Oct 2024 31 Dec 2024 10-K 15 Apr 2025
Q3 2024 -$95M -$38.8M -$12M -44.6% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025
Q2 2024 -$83.1M $23.3M +$35.7M 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 -$119M -$62.8M -$63.6M -8816% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2024
Q4 2023 -$55.2M -$16.7M -$21.2M -467% 01 Oct 2023 31 Dec 2023 10-K 15 Apr 2025
Q3 2023 -$34M -$26.9M -$27.1M -10639% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 -$6.88M -$12.4M -$8.07M -186% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024
Q1 2023 $1.18M $721K +$741K 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 $442K $4.54M +$4.59M 01 Oct 2022 31 Dec 2022 10-K 06 Mar 2024
Q3 2022 -$4.15M $255K +$243K +2025% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 -$4.39M -$4.34M -$4.38M -9326% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 -$6K -$20K -$40K -200% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $34K -$45K -$110K -169% 01 Oct 2021 31 Dec 2021 10-K 23 Mar 2023
Q3 2021 $144K $12K -$109K -90.1% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022
Q2 2021 $253K $47K -$174K -78.7% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 $427K $20K -$78K -79.6% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 $505K $65K 01 Oct 2020 31 Dec 2020 10-K 10 Mar 2022
Q3 2020 $121K +$87K +256% 01 Jul 2020 30 Sep 2020 10-Q 12 Nov 2021
Q2 2020 $221K 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $98K +$99K 01 Jan 2020 31 Mar 2020 10-Q 11 May 2021
Q3 2019 $34K +$991K 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q1 2019 -$2.54M -$1K* +$466K 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020
Q4 2018 -$3M -$731K 01 Oct 2018 31 Dec 2018 10-K 13 Mar 2020
Q3 2018 -$957K 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2019
Q2 2018 -$848K 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019
Q1 2018 -$467K 01 Jan 2018 31 Mar 2018 10-Q 21 Jun 2019

Applied Therapeutics, Inc. Annual Nonoperating Income (Expense) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$1.33M +$53.9M +97.6% 01 Jan 2024 31 Dec 2024 10-K 15 Apr 2025
2023 -$55.2M -$55.7M -12595% 01 Jan 2023 31 Dec 2023 10-K 15 Apr 2025
2022 $442K +$408K +1200% 01 Jan 2022 31 Dec 2022 10-K 06 Mar 2024
2021 $34K -$471K -93.3% 01 Jan 2021 31 Dec 2021 10-K 23 Mar 2023
2020 $505K +$436K +632% 01 Jan 2020 31 Dec 2020 10-K 10 Mar 2022
2019 $69K +$3.07M 01 Jan 2019 31 Dec 2019 10-K 18 Mar 2021
2018 -$3M 01 Jan 2018 31 Dec 2018 10-K 13 Mar 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.